Analysts at StockNews.com started coverage on shares of United-Guardian (NASDAQ:UG – Get Free Report) in a research note issued to investors on Thursday. The firm set a “buy” rating on the stock.
United-Guardian Trading Down 1.7 %
NASDAQ:UG opened at $10.69 on Thursday. United-Guardian has a 1 year low of $7.02 and a 1 year high of $16.25. The firm has a 50 day moving average of $9.94 and a 200-day moving average of $11.86.
United-Guardian (NASDAQ:UG – Get Free Report) last announced its earnings results on Friday, November 8th. The company reported $0.19 earnings per share for the quarter. The company had revenue of $3.06 million during the quarter. United-Guardian had a return on equity of 30.25% and a net margin of 28.30%.
Institutional Inflows and Outflows
United-Guardian Company Profile
United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.
Recommended Stories
- Five stocks we like better than United-Guardian
- 3 Stocks to Consider Buying in October
- Oracle Announces Game-Changing News for the AI Industry
- What Are Dividend Achievers? An Introduction
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- When to Sell a Stock for Profit or Loss
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.